Molecular studies of HPV+ HNSCC in the past focused primarily on tumor suppressor pathways that are targeted by viral oncoproteins such as E6, which inactivates the p53 tumor suppressor protein by instigating its degradation (9). This evidence concerns the gene TCHP and head and neck squamous cell carcinoma.